2022 Genetics and Epigenetics Cross-Cutting Research Team (GECCRT) Meeting
The GECCRT is sponsored by the National Institute on Drug Abuse (NIDA) and has members from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Mental Health (NIMH). Our mission is to develop NIDA’s portfolio of genetic and epigenetic research relevant to substance use disorders and addictive behaviors.
What We Do:
The NIDA Genetics Consortium was founded in 1999 to coordinate efforts of investigators studying substance use disorders and addictive behaviors. The NGC encompasses consortia on Human Genetics of Substance Use Disorders and Animal Models of Addictive Behaviors.
NIDA has created a list of domains and their associated measures to help with the harmonization of data in the area of genetic studies.
- Genetics Data Harmonization
- PhenX Substance Abuse and Addiction (SAA) Project
- NIDA Center For Genetic Studies (cell and DNA biorepository)
Policies for access and distribution of DNA and clinical data from NIDA-funded studies on the genetics of addiction vulnerability
- Distribution of genetic data and biomaterials from the NIDA Center for Genetic Studies
- NIDA Distribution Agreement
- FAQs Related to the NIDA Genetic Studies, and Data and Biospecimen Submission and Access Through NIDA and NIH Resources
Collaborative Resources for Genetics
- Directory of Investigators Interested in Genetics and Epigenetics of Substance Abuse
For questions or concerns regarding the Human Genetics Consortium and/or for access to the collaborative networking site, please contact:
Jonathan D. Pollock, Ph.D.
Co-Chair, Genetics and Epigenetics Cross-Cutting Research Team
6001 Executive Drive, RM 4274
Bethesda, MD 20892
For questions, concerns, or access the Animal Models of Addictive Behaviors Consortium, please contact:
Amy C. Lossie, Ph.D.
6001 Executive Drive, RM 4261
Bethesda, MD 20892